Ali Afshar-Oromieh1,2, Maya Wolf3, Uwe Haberkorn4,5, Marc Kachelrieß6, Regula Gnirs3, Klaus Kopka7, Heinz-Peter Schlemmer3, Martin T Freitag3. 1. Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany. a.afshar@gmx.de. 2. Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany. a.afshar@gmx.de. 3. Department of Radiology, German Cancer Research Center, Heidelberg, Germany. 4. Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany. 5. Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany. 6. Department of Medical Physics in Radiology, German Cancer Research Center, Heidelberg, Germany. 7. Division of Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg, Germany.
Abstract
PURPOSE: PSMA ligand imaging with hybrid PET/MRI scanners could be an integral part of the clinical routine in the future. However, the first study about this novel method revealed a severe photopenic artifact ("halo artifact") around the urinary bladder causing significantly reduced tumor visibility. The aim of this evaluation was to analyze the role of arm truncation on the appearance of the halo artifact in 68Ga-PSMA-11 PET/MRI hypothesizing that this influences the appearance. METHODS: Twenty-seven consecutive patients were subjected to 68Ga-PSMA-11 PET/CT (1 h p.i.) followed by PET/MRI (3 h p.i.). PET/MRI was first started with scans of the abdomen to pelvis with arms positioned up above the head. Immediately thereafter, additional scans from the pelvis to abdomen were conducted with arms positioned down beside the trunk. All investigations were first analyzed separately and then compared with respect to tumor detection and tumor uptake (SUV) as well as the presence and intensity of the halo artifact. The Wilcoxon signed rank test was used to determine statistical differences including Bonferroni correction. RESULTS: The halo was significantly reduced if the arms were elevated. Lesions inside the halo artifact (n = 16) demonstrated significantly increased SUVmean (p = 0.0007) and SUVmax (p = 0.0024) with arms positioned up. The halo appearance and intensity was not dependent on the total activity and activity concentration of the urinary bladder. CONCLUSION: Positioning the arms down was shown to be significantly associated with the appearance of the halo artifact in PET/MRI. Positioning the arms up above the head can significantly reduce the halo artifact, thereby detecting more tumor lesions.
PURPOSE:PSMA ligand imaging with hybrid PET/MRI scanners could be an integral part of the clinical routine in the future. However, the first study about this novel method revealed a severe photopenic artifact ("halo artifact") around the urinary bladder causing significantly reduced tumor visibility. The aim of this evaluation was to analyze the role of arm truncation on the appearance of the halo artifact in 68Ga-PSMA-11 PET/MRI hypothesizing that this influences the appearance. METHODS: Twenty-seven consecutive patients were subjected to 68Ga-PSMA-11 PET/CT (1 h p.i.) followed by PET/MRI (3 h p.i.). PET/MRI was first started with scans of the abdomen to pelvis with arms positioned up above the head. Immediately thereafter, additional scans from the pelvis to abdomen were conducted with arms positioned down beside the trunk. All investigations were first analyzed separately and then compared with respect to tumor detection and tumor uptake (SUV) as well as the presence and intensity of the halo artifact. The Wilcoxon signed rank test was used to determine statistical differences including Bonferroni correction. RESULTS: The halo was significantly reduced if the arms were elevated. Lesions inside the halo artifact (n = 16) demonstrated significantly increased SUVmean (p = 0.0007) and SUVmax (p = 0.0024) with arms positioned up. The halo appearance and intensity was not dependent on the total activity and activity concentration of the urinary bladder. CONCLUSION: Positioning the arms down was shown to be significantly associated with the appearance of the halo artifact in PET/MRI. Positioning the arms up above the head can significantly reduce the halo artifact, thereby detecting more tumor lesions.
Authors: Matthias C Roethke; Timur H Kuru; Ali Afshar-Oromieh; Heinz-Peter Schlemmer; Boris A Hadaschik; Michael Fenchel Journal: Eur Urol Date: 2013-08-09 Impact factor: 20.096
Authors: Ali Afshar-Oromieh; Lars Peter Sattler; Walter Mier; Boris A Hadaschik; Jürgen Debus; Tim Holland-Letz; Klaus Kopka; Uwe Haberkorn Journal: J Nucl Med Date: 2017-01-06 Impact factor: 10.057
Authors: A Afshar-Oromieh; U Haberkorn; H P Schlemmer; M Fenchel; M Eder; M Eisenhut; B A Hadaschik; A Kopp-Schneider; M Röthke Journal: Eur J Nucl Med Mol Imaging Date: 2013-12-19 Impact factor: 9.236
Authors: Martin T Freitag; Jan P Radtke; Ali Afshar-Oromieh; Matthias C Roethke; Boris A Hadaschik; Martin Gleave; David Bonekamp; Klaus Kopka; Matthias Eder; Thorsten Heusser; Marc Kachelriess; Kathrin Wieczorek; Christos Sachpekidis; Paul Flechsig; Frederik Giesel; Markus Hohenfellner; Uwe Haberkorn; Heinz-Peter Schlemmer; A Dimitrakopoulou-Strauss Journal: Eur J Nucl Med Mol Imaging Date: 2016-12-17 Impact factor: 9.236
Authors: Johannes Schwenck; Hansjoerg Rempp; Gerald Reischl; Stephan Kruck; Arnulf Stenzl; Konstantin Nikolaou; Christina Pfannenberg; Christian la Fougère Journal: Eur J Nucl Med Mol Imaging Date: 2016-08-24 Impact factor: 9.236
Authors: Ali Afshar-Oromieh; Henrik Hetzheim; Wolfgang Kübler; Clemens Kratochwil; Frederik L Giesel; Thomas A Hope; Matthias Eder; Michael Eisenhut; Klaus Kopka; Uwe Haberkorn Journal: Eur J Nucl Med Mol Imaging Date: 2016-06-03 Impact factor: 9.236
Authors: A Afshar-Oromieh; A Malcher; M Eder; M Eisenhut; H G Linhart; B A Hadaschik; T Holland-Letz; F L Giesel; C Kratochwil; S Haufe; U Haberkorn; C M Zechmann Journal: Eur J Nucl Med Mol Imaging Date: 2012-11-24 Impact factor: 9.236
Authors: Christian Uprimny; Steffen Bayerschmidt; Alexander Stephan Kroiss; Josef Fritz; Bernhard Nilica; Anna Svirydenka; Clemens Decristoforo; Gianpaolo di Santo; Elisabeth von Guggenberg; Wolfgang Horninger; Irene Johanna Virgolini Journal: Eur J Nucl Med Mol Imaging Date: 2020-05-08 Impact factor: 9.236
Authors: Benedikt Kranzbühler; Hannes Nagel; Anton S Becker; Julian Müller; Martin Huellner; Paul Stolzmann; Urs Muehlematter; Matthias Guckenberger; Philipp A Kaufmann; Daniel Eberli; Irene A Burger Journal: Eur J Nucl Med Mol Imaging Date: 2017-10-14 Impact factor: 9.236
Authors: Thorsten Heußer; Philipp Mann; Christopher M Rank; Martin Schäfer; Antonia Dimitrakopoulou-Strauss; Heinz-Peter Schlemmer; Boris A Hadaschik; Klaus Kopka; Peter Bachert; Marc Kachelrieß; Martin T Freitag Journal: PLoS One Date: 2017-08-17 Impact factor: 3.240
Authors: Ali Afshar-Oromieh; Nils Debus; Monika Uhrig; Thomas A Hope; Michael J Evans; Tim Holland-Letz; Frederik L Giesel; Klaus Kopka; Boris Hadaschik; Clemens Kratochwil; Uwe Haberkorn Journal: Eur J Nucl Med Mol Imaging Date: 2018-07-07 Impact factor: 9.236
Authors: Hong Grafe; Maike E Lindemann; Verena Ruhlmann; Mark Oehmigen; Nader Hirmas; Lale Umutlu; Ken Herrmann; Harald H Quick Journal: Eur J Nucl Med Mol Imaging Date: 2020-03-03 Impact factor: 9.236
Authors: Courtney Lawhn-Heath; Robert R Flavell; David E Korenchan; Timothy Deller; Spencer Lake; Peter R Carroll; Thomas A Hope Journal: Mol Imaging Date: 2018 Jan-Dec Impact factor: 4.488